Teresa A. Seville, M.D.

  1. Infectious Disease Specialist
  1. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Clement J, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Trimethoprim-sulfamethoxazole dosing and outcomes of pulmonary nocardiosis. Infection. 2024 Jun 26 Epub 2024 June 26
    View PubMed
  2. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infect Dis. 2024 Apr; 11 (4):ofae122 Epub 2024 Mar 01
    View PubMed
  3. Yetmar ZA, Kudva YC, Seville MT, Bosch W, Huskey JL, Jarmi T, Kukla A, Dean PG, Razonable RR, Beam E. Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation. Am J Transplant. 2024 Feb; 24 (2):271-279 Epub 2023 Oct 13
    View PubMed
  4. Speiser LJ, Wonnaparhown AM, Blair J, Shah A, Patel DR, McCullough AE, Nicolasora N, Khalsa AM, Orenstein R, Vikram HR, Huang V, Seville MT. A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss. Open Forum Infect Dis. 2024 Jan; 11 (1):ofad632 Epub 2023 Dec 14
    View PubMed
  5. Yetmar ZA, Kudva YC, Seville MT, Bosch W, Dean PG, Huskey JL, Budhiraja P, Jarmi T, Kukla A, Beam E. BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas-kidney recipients. Clin Transplant. 2023 Nov; 37 (11):e15135 Epub 2023 Sept 13
    View PubMed
  6. Grant LM, Seville MT, Graf EH, Vikram HR. Rhodococcus erythropolis septic arthritis. BMJ Case Rep. 2023 Oct 6; 16 (10) Epub 2023 Oct 06
    View PubMed
  7. Yetmar ZA, Chesdachai S, Khodadadi RB, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Outcomes of transplant recipients with pretransplant Nocardia colonization or infection. Transpl Infect Dis. 2023 Oct; 25 (5):e14097 Epub 2023 June 28
    View PubMed
  8. Yetmar ZA, Chesdachai S, Duffy D, Smith BH, Challener DW, Seville MT, Bosch W, Beam E. Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study. Clin Transplant. 2023 Sep; 37 (9):e15016 Epub 2023 May 11
    View PubMed
  9. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection. Open Forum Infect Dis. 2023 Aug; 10 (8):ofad409 Epub 2023 Aug 01
    View PubMed
  10. Yetmar ZA, McCord M, Lahr BD, Kudva YC, Seville MT, Bosch W, Lemke A, Katariya NN, Reddy KS, Perry DK, Huskey JL, Jarmi T, Kukla A, Dean PG, Bernard SA, Beam E. Impact of Perioperative Prophylaxis With Enterococcus Activity on Risk of Surgical-Site Infection After Pancreas Transplantation. Transplant Direct. 2023 Jul; 9(7):e1496. Epub 2023 Jun 08.
    View PubMed
  11. Yetmar ZA, Chesdachai S, Lahr BD, Challener DW, Arensman Hannan KN, Epps K, Stevens RW, Seville MT, Tande AJ, Virk A. Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis. Antimicrob Agents Chemother. 2023 Jun 15; 67 (6):e0012023 Epub 2023 May 16
    View PubMed
  12. Gupta S, Cunningham CA, Grant LM, Abdou MM, Graf EH, Seville MT. Dual infection with Alternaria and Nocardia in a renal transplant patient. Transpl Infect Dis. 2023 Jun; 25 (3):e14026 Epub 2023 Feb 07
    View PubMed
  13. Speiser LJ, Graf EH, Seville MT, Singbartl K, Dalton ML, Harrington D, Kretschmer M, Kuljanin M, Zabel K, Sunenshine R, Ruberto I, Venkat H, Grys TE. Burkholderia pseudomallei Laboratory Exposure, Arizona, USA. Emerg Infect Dis. 2023 May; 29 (5):1061-1063
    View PubMed
  14. Yetmar ZA, Thoendel MJ, Bosch W, Seville MT, Hogan WJ, Beam E. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients. Transplant Cell Ther. 2023 Mar; 29 (3):206.e1-206.e7 Epub 2022 Dec 13
    View PubMed
  15. Yetmar ZA, Challener DW, Seville MT, Bosch W, Beam E. Outcomes of Nocardiosis and Treatment of Disseminated Infection in Solid Organ Transplant Recipients. Transplantation. 2023 Mar 1; 107 (3):782-791 Epub 2022 Oct 28
    View PubMed
  16. Chan L, Gupta S, Sacco AJ, Kasule SN, Chaffin H, Feller FF, Mi L, Lim ES, Seville MT. Infections and antimicrobial prescribing in patients hospitalized with coronavirus disease 2019 (COVID-19) during the first pandemic wave. Antimicrob Steward Healthc Epidemiol. 2023; 3 (1):e75 Epub 2023 Apr 17
    View PubMed
  17. Yetmar ZA, O'Horo JC, Seville MT, Speicher LL, Ganesh R, Razonable RR. Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination. Transplantation 2022 Nov 1; 106 (11):e507-e509 Epub 2022 Aug 15
    View PubMed
  18. Cash-Goldwasser S, Labuda SM, McCormick DW, Rao AK, McCollum AM, Petersen BW, Chodosh J, Brown CM, Chan-Colenbrander SY, Dugdale CM, Fischer M, Forrester A, Griffith J, Harold R, Furness BW, Huang V, Kaufman AR, Kitchell E, Lee R, Lehnertz N, Lynfield R, Marsh KJ, Madoff LC, Nicolasora N, Patel D, Pineda R, Powrzanas T, Roberts A, Seville MT, Shah A, Wong JM, Ritter JM, Schrodt CA, Raizes E, Morris SB, Gold JAW. Ocular monkeypox -- United States, July--September 2022. MMWR-Morbidity and Mortality Weekly Report. 2022 Oct 21; 71 (42):1343-7
  19. Yetmar ZA, Beam E, O'Horo JC, Seville MT, Brumble L, Ganesh R, Razonable RR. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch. Transpl Infect Dis. 2022 Aug; 24 (4):e13901 Epub 2022 July 25
    View PubMed
  20. Yetmar ZA, Khodadadi RB, Seville MT, Brumble L, O'Horo JC, Ganesh R, Razonable RR. Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies. Open Forum Infect Dis. 2022 Jul; 9 (7):ofac204 Epub 2022 Apr 14
    View PubMed
  21. Mueller JT, Karimi S, Poterack KA, Seville MTA, Tipton SM. Double masking: Does science coincide with common sense? Infect Control Hosp Epidemiol. 2022 Jul; 43 (7):954-955 Epub 2021 Apr 07
    View PubMed
  22. O'Horo JC, Challener DW, Speicher L, Bosch W, Seville MT, Bierle DM, Ganesh R, Wilker CG, Arndt RF, Arndt LL, Tulledge-Scheitel SM, Hanson SN, Razonable RR. Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant. Mayo Clin Proc. 2022 Feb; 97 (2):327-332 Epub 2021 Dec 16
    View PubMed
  23. Jayasekera CR, Vikram HR, Rifat Z, Wagler J, Okubo K, Braaksma BR, Harbell JW, Jadlowiec CC, Katariya NN, Mathur AK, Moss A, Reddy KS, Singer A, Orenstein R, Saling CF, Seville MT, Mour GK, Vargas HE, Byrne TJ, Hewitt WR Jr, Aqel BA. Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience. Transplant Direct. 2022 Feb; 8 (2):e1286 Epub 2022 Jan 13
    View PubMed
  24. Gupta S, Kasule SN, Seville MT. Cerebral abscess with Streptococcus intermedius as a complication of pelvic inflammatory disease in the setting of intrauterine device use. IDCases. 2022; 27:e01454 Epub 2022 Feb 17
    View PubMed
  25. Ganesh R, Philpot LM, Bierle DM, Anderson RJ, Arndt LL, Arndt RF, Culbertson TL, Destro Borgen MJ, Hanson SN, Kennedy BD, Kottke BB, Larsen JJ, Ramar P, Rosedahl JK, Seville MT, Speicher LL, Tulledge-Scheitel SM, Wilker CG, Razonable RR. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 Oct 28; 224 (8):1278-1286
    View PubMed
  26. Razonable RR, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Ganesh R. Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19. EClinicalMedicine. 2021 Oct; 40:101102 Epub 2021 Aug 30
    View PubMed
  27. Blair JE, Gotimukul A, Wang F, Mina SA, Bartels HC, Burns MW, Kole AE, Vikram HR, Gea-Banacloche JC, Seville MT, Petty SAB, Vikram A, Orenstein R. Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness. Medicine (Baltimore). 2021 Jun 18; 100 (24):e26371
    View PubMed
  28. Yetmar ZA, Beam E, O'Horo JC, Ganesh R, Bierle DM, Brumble L, Seville MT, Razonable RR. Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients. Open Forum Infect Dis. 2021 Jun; 8 (6):ofab255 Epub 2021 June 07
    View PubMed
  29. Razonable RR, Aloia NCE, Anderson RJ, Anil G, Arndt LL, Arndt RF, Ausman SE, Bell SJ, Bierle DM, Billings ML, Bishop RK, Cramer CH, Culbertson TL, Dababneh AS, Derr AN, Epps K, Flaker SM, Ganesh R, Gilmer MA, Urena EG, Gulden CR, Haack TL, Hanson SN, Herzog JR, Heyliger A, Hokanson LD, Hopkins LH, Horecki RJ, Krishna BH, Huskins WC, Jackson TA, Johnson RR, Jorgenson B, Kudrna C, Kennedy BD, Klingsporn MK, Kottke B, Larsen JJ, Lessard SR, Lutwick LI, Malone EJ 3rd, Matoush JA, Micallef IN, Moehnke DE, Mohamed M, Ness CN, Olson SM, Orenstein R, Palraj R, Patel J, Paulson DJ, Phelan D, Peinovich MT, Ramsey WL, Rau-Kane TJ, Reid KI, Reinschmidt KJ, Seville MT, Skold EC, Smith JM, Speicher LL, Spielman LA, Springer DJ, Sweeten PW, Tempelis JM, Tulledge-Scheitel S, Vergidis P, Whipple DC, Wilker CG, Destro Borgen MJ. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 May; 96 (5):1250-1261 Epub 2021 Mar 09
    View PubMed
  30. Mueller JT, Karimi S, Poterack KA, Seville MTA, Tipton SM. Surgical mask covering of N95 filtering facepiece respirators: The risk of increased leakage. Infect Control Hosp Epidemiol. 2021 May; 42 (5):627-628 Epub 2021 Feb 09
    View PubMed
  31. Reynolds JL, Trudeau RE, Seville MT, Chan L. Impact of a vancomycin-resistant Enterococcus (VRE) screening result on appropriateness of antibiotic therapy. Antimicrob Steward Healthc Epidemiol. 2021; 1 (1):e41 Epub 2021 Nov 03
    View PubMed
  32. Saling CF, Seville MT, Patron RL. The effect of gastrointestinal pathogen panel (GIP) on antibiotic management. Antimicrob Steward Healthc Epidemiol. 2021; 1 (1):e5 Epub 2021 June 24
    View PubMed
  33. Ali-Mucheru MN, Seville MT, Miller V, Sampathkumar P, Etzioni DA. Postoperative Surgical Site Infections: Understanding the Discordance Between Surveillance Systems. Ann Surg. 2020 Jan; 271 (1):94-99
    View PubMed
  34. Orenstein R, Patron RL, Seville MT. Why Does Clostridium difficile Infection Recur? J Am Osteopath Assoc. 2019 May 1; 119 (5):322-326
    View PubMed
  35. Mafi N, Yaglom HD, Levy C, Taylor A, O'Grady C, Venkat H, Komatsu KK, Roller B, Seville MT, Kusne S, Po JL, Thorn S, Ampel NM. Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013-2018. Emerg Infect Dis. 2019 Apr; 25 (4):649-653
    View PubMed
  36. Tseng AS, Kasule SN, Rice F, Mi L, Chan L, Seville MT, Grys TE. Is It Actionable? An Evaluation of the Rapid PCR-Based Blood Culture Identification Panel on the Management of Gram-Positive and Gram-Negative Blood Stream Infections. Open Forum Infect Dis. 2018 Dec; 5 (12):ofy308 Epub 2018 Dec 11
    View PubMed
  37. Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K. The Brief Case: The Unexpected Souvenir. J Clin Microbiol. 2018 Sep; 56 (9) Epub 2018 Aug 27
    View PubMed
  38. Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K. Closing the Brief Case: The Unexpected Souvenir. J Clin Microbiol 2018 Sep; 56 (9) Epub 2018 Aug 27
    View PubMed
  39. Cho J, Seville MT, Khanna S, Pardi DS, Sampathkumar P, Kashyap PC. Screening for Clostridium difficile colonization on admission to a hematopoietic stem cell transplant unit may reduce hospital-acquired C difficile infection. Am J Infect Control. 2018 Apr; 46 (4):459-461 Epub 2017 Nov 21
    View PubMed
  40. Hartmann CA, Vikram HR, Seville MT, Orenstein R, Kusne S, Blair JE, Grys TE, Patron RL. Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients. Am J Transplant. 2017 Aug; 17 (8):2200-2206 Epub 2017 May 27
    View PubMed
  41. Fitterer C, Berg Z, Halfdanarson TR, Vikram HR, Kusne S, Orenstein R, Seville MT, Blair JE. Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature. Mycopathologia. 2016 Dec; 181 (11-12):787-798 Epub 2016 Aug 04
    View PubMed
  42. Chan NH, Blair JE, Westphal SA, Tehrani LK, Seville MA. Fluconazole-Associated Hypercalcemia in Patients with Coccidioidomycosis J Clin Case Rep. 2016 May; 6:800.
  43. Campbell M, Kusne S, Renfree KJ, Vikram HR, Smilack JD, Seville MT, Orenstein R, Blair JE. Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the Literature. Clin Infect Dis. 2015 Nov 15; 61: (10)1514-20.
    View PubMed
  44. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, Kusne S, Ho S, Seville MT, Parish JM. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014 Jun; 20(6):983-90.
    View PubMed
  45. Mueller JT, Wright AJ, Fedraw LA, Murad MH, Brown DR, Thompson KM, Flick R, Seville MT, Huskins WC. Standardizing central line safety: lessons learned for physician leaders. Am J Med Qual. 2014 May-Jun; 29(3):191-9. Epub 2013 Jul 23.
    View PubMed
  46. Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014 Feb; 42 (1):105-11 Epub 2013 Aug 24
    View PubMed
  47. Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother. 2014; 58 (2):859-64 Epub 2013 Nov 25
    View PubMed
  48. Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013 Aug; 67(2):148-55. Epub 2013 Apr 6
    View PubMed
  49. Punatar AD, Kusne S, Blair JE, Seville MT, Vikram HR. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect. 2012 Aug; 65: (2)173-9.
    View PubMed
  50. Maduka-Ezeh A, Seville MT, Kusne S, Vikram HR, Blair JE, Greenwood-Quaintance K, Arabia F, Patel R. Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection. J Clin Microbiol. 2012 Mar; 50 (3):1102-5 Epub 2012 Jan 11
    View PubMed
  51. Kim MM, Vikram HR, Kusne S, Seville MT, Blair JE. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011 Dec; 53(11):1060-6.
    View PubMed
  52. Keckich DW, Blair JE, Vikram HR, Seville MT, Kusne S. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation. 2011 Jul 15; 92 (1):88-93
    View PubMed
  53. Seville MT, Blair JE, Vikram HR, Kusne S. 2009 H1N1 influenza in hospitalized transplant recipients. Transplantation. 2010 Sep 15; 90(5):571-4.
    View PubMed
  54. Bhatti MA, Seville MT. Images in clinical medicine. Hematogenous anaerobic osteomyelitis.[see comment]. N Engl J Med. 2002 Apr 4; 346(14):1060.
    View PubMed
  55. Bhatti MA, Seville MT, Sohnle PG. Derma dilemma: mucormycosis. Hosp Physician. 2000; 36(5):57-9.
  56. Seville MT. HIV in the elderly. Saint Francis Medical Proceedings. 1993; 3(3):10-1.